{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:11Z","timestamp":1790283851084,"version":"4.1.0"},"reference-count":407,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PON-MIUR 03PE000_78_1"],"award-info":[{"award-number":["PON-MIUR 03PE000_78_1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PONMIUR 03PE000_78_2"],"award-info":[{"award-number":["PONMIUR 03PE000_78_2"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.phrs.2023.106931","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:10:59Z","timestamp":1694866259000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment"],"prefix":"10.1016","volume":"196","author":[{"given":"Rocco","family":"Mollace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Maiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Tavernese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Gliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Musolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Muscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Muscoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salvemini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Macr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106931_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"ESC Sci. Doc. Group. Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib3","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4070\/kcj.2021.0401","article-title":"Medical management of patients with heart failure and reduced ejection fraction","volume":"52","author":"Greenberg","year":"2022","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.phrs.2023.106931_bib6","first-page":"1219","article-title":"FDA expands empagliflozin heart failure indication","volume":"327","author":"Larkin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2023.106931_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.120.051783","article-title":"Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-reduced trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib9","first-page":"1342","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert","year":"2022","journal-title":"Heart (Br. Card. Soc.)"},{"key":"10.1016\/j.phrs.2023.106931_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1310\/hpj5006-454","article-title":"Treating heart failure with preserved ejection fraction: a challenge for clinicians","volume":"50","author":"Howard","year":"2015","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib11","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/ejhf.2249","article-title":"Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial","volume":"23","author":"Solomon","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"28","author":"Writing Committee Members, & ACC\/AHA Joint Committee Members","year":"2022","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14779072.2018.1497485","article-title":"Mechanisms, diagnosis, and treatment of heart failure with preserved ejection fraction and diastolic dysfunction","volume":"16","author":"Plitt","year":"2018","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14336\/AD.2022.0523","article-title":"The NO-cGMP-PKG Axis in HFpEF: from pathological mechanisms to potential therapies","volume":"14","author":"Cai","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2023.106931_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbadis.2018.09.026","article-title":"Dietary nitrate's effects on exercise performance in heart failure with reduced ejection fraction (HFrEF)","volume":"1865","author":"Mulkareddy","year":"2019","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2023.106931_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/014107689909200402","article-title":"Nitric oxide: discovery and impact on clinical medicine","volume":"92","author":"Moncada","year":"1999","journal-title":"J. R. Soc. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","article-title":"Nitric oxide signalling in cardiovascular health and disease","volume":"15","author":"Farah","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/FJC.0000000000000749","article-title":"cGMP signaling and modulation in heart failure","volume":"75","author":"Blanton","year":"2020","journal-title":"J. Cardiovasc Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000536","article-title":"The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction","volume":"2","author":"Greene","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106931_bib21","doi-asserted-by":"crossref","first-page":"1921-7","DOI":"10.1016\/j.jacc.2011.09.086","article-title":"Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection","volume":"59","author":"Kukreja","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/FJC.0000000000000773","article-title":"Myocardial phosphodiesterases and their role in cGMP regulation","volume":"75","author":"Dunkerly-Eyring","year":"2020","journal-title":"J. Cardiovasc. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib24","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1210\/me.2013-1159","article-title":"Regulation of iNOS gene transcription by IL-1\u03b2 and IFN-\u03b3 requires a coactivator exchange mechanism","volume":"27","author":"Burke","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2023.106931_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bph.14522","article-title":"Endothelial NOS: perspective and recent developments","volume":"176","author":"Garcia","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.52586\/4926","article-title":"Regulation of NOS expression in vascular diseases","volume":"26","author":"Pautz","year":"2021","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.phrs.2023.106931_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/1874192401105010153","article-title":"Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure","volume":"5","author":"Soski\u0107","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.phrs.2023.106931_bib28","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.3390\/ijms232415454","article-title":"The generation of nitric oxide from aldehyde dehydrogenase-2: the role of dietary nitrates and their implication in cardiovascular disease management","volume":"23","author":"Maiuolo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106931_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","article-title":"Nitric oxide and cardiac function: ten years after, and continuing","volume":"93","author":"Massion","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-0038-1655925","article-title":"Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets","volume":"77","author":"Wallerath","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2023.106931_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.00042.2007","article-title":"eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues","volume":"89","author":"Balligand","year":"2009","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.phrs.2023.106931_bib33","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.RES.0000168807.63013.56","article-title":"p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols","volume":"96","author":"Anter","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib34","doi-asserted-by":"crossref","first-page":"35087","DOI":"10.1074\/jbc.M405063200","article-title":"The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation","volume":"279","author":"Chan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11239-018-1684-4","article-title":"microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3","volume":"46","author":"Qin","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.phrs.2023.106931_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/bph.14522","article-title":"Endothelial NOS: perspective and recent developments","volume":"176","author":"Garcia","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib37","doi-asserted-by":"crossref","first-page":"22810","DOI":"10.1074\/jbc.271.37.22810","article-title":"Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells","volume":"271","author":"Feron","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib38","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.93.13.6448","article-title":"Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling","volume":"93","author":"Garc\u00eda-Carde\u00f1a","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/21224","article-title":"Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation","volume":"399","author":"Dimmeler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106931_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00424-009-0767-7","article-title":"Molecular mechanisms underlying the activation of eNOS","volume":"459","author":"Fleming","year":"2010","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.phrs.2023.106931_bib41","doi-asserted-by":"crossref","first-page":"35943","DOI":"10.1074\/jbc.M504606200","article-title":"Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83","volume":"280","author":"Fulton","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib42","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.2174\/13816128113196660745","article-title":"Regulation of eNOS enzyme activity by posttranslational modification","volume":"20","author":"Heiss","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2023.106931_bib43","doi-asserted-by":"crossref","first-page":"19888","DOI":"10.1074\/jbc.M413058200","article-title":"Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells","volume":"280","author":"Erwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/aps.2011.21","article-title":"A molecular switch of \"yin and yang\": S-glutathionylation of eNOS turns off NO synthesis and turns on superoxide generation","volume":"32","author":"Duan","year":"2011","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2023.106931_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib46","doi-asserted-by":"crossref","first-page":"27580","DOI":"10.1016\/S0021-9258(18)47024-X","article-title":"Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro","volume":"269","author":"Balligand","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib47","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.3390\/ijms20133294","article-title":"Modulation of nitric oxide synthases by oxidized LDLs: Role in vascular inflammation and atherosclerosis development","volume":"20","author":"Gliozzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib48","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1073\/pnas.192345199","article-title":"Ubiquitination of inducible nitric oxide synthase is required for its degradation","volume":"99","author":"Kolodziejski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib49","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000264081.78659.45","article-title":"Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure","volume":"100","author":"Zhang","year":"2007","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib50","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.3390\/ijms232415454","article-title":"The generation of nitric oxide from aldehyde dehydrogenase-2: the role of dietary nitrates and their implication in cardiovascular disease management","volume":"23","author":"Maiuolo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.freeradbiomed.2004.04.027","article-title":"Inorganic nitrate is a possible source for systemic generation of nitric oxide","volume":"37","author":"Lundberg","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib52","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm954","article-title":"Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation","volume":"9","author":"Cosby","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib53","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/CIRCRESAHA.108.175810","article-title":"Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase","volume":"103","author":"Webb","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cmet.2006.02.011","article-title":"Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes","volume":"3","author":"Castello","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2023.106931_bib55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.freeradbiomed.2013.06.031","article-title":"Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex","volume":"65","author":"Velmurugan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2023.106931_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/HYPERTENSIONAHA.114.04675","article-title":"Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study","volume":"65","author":"Kapil","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib57","doi-asserted-by":"crossref","first-page":"13683","DOI":"10.1073\/pnas.0402927101","article-title":"Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage","volume":"102","author":"Webb","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1681\/ASN.2006050450","article-title":"Nitrite-derived nitric oxide protects the rat kidney against ischemia\/reperfusion injury in vivo: role for xanthine oxidoreductase","volume":"18","author":"Tripatara","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2023.106931_bib59","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.jacc.2013.03.050","article-title":"Low-dose sodium nitrite attenuates myocardial ischemia and vascular ischemia-reperfusion injury in human models","volume":"61","author":"Ingram","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/CIRCULATIONAHA.112.112912","article-title":"Dietary nitrate supplementation improves revascularization in chronic ischemia","volume":"126","author":"Hendgen-Cotta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.freeradbiomed.2011.11.018","article-title":"Decreased leukocyte recruitment by inorganic nitrate and nitrite in microvascular inflammation and NSAID-induced intestinal injury","volume":"52","author":"J\u00e4dert","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib62","first-page":"H314","article-title":"Role of leukocytes in response to acute myocardial ischemia and reflow in dogs","volume":"251","author":"Engler","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.117.029058","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis","volume":"137","author":"Houstis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib64","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/CIRCRESAHA.114.301475","article-title":"Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling","volume":"114","author":"Bhushan","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib65","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2015.07.067","article-title":"Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction","volume":"66","author":"Borlaug","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib66","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/gutjnl-2016-313316","article-title":"Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction","volume":"67","author":"Catry","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2023.106931_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-62703-459-3_1","article-title":"NO\/cGMP: the past, the present, and the future","volume":"1020","author":"Russwurm","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbagen.2011.07.010","article-title":"Protein S-nitrosylation: role for nitric oxide signaling in neuronal death","volume":"1820","author":"Shahani","year":"2012","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2023.106931_bib69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0163-7258(99)00072-8","article-title":"Paracrine and autocrine effects of nitric oxide on myocardial function","volume":"86","author":"Shah","year":"2000","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib70","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature11626","article-title":"Endothelial cell expression of haemoglobin \u03b1 regulates nitric oxide signalling","volume":"491","author":"Straub","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106931_bib71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.freeradbiomed.2017.08.025","article-title":"The NO-heme signaling hypothesis","volume":"112","author":"Kleschyov","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib72","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1074\/jbc.RA117.000457","article-title":"Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase","volume":"293","author":"Wales","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib73","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1096\/fasebj.7.2.7680013","article-title":"Intracellular cyclic GMP receptor proteins","volume":"7","author":"Lincoln","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2023.106931_bib74","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2007.02.031","article-title":"Phosphodiesterase regulation of nitric oxide signaling","volume":"75","author":"Kass","year":"2007","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2023.106931_bib75","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.yjmcc.2011.07.029","article-title":"Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling","volume":"52","author":"Hammond","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2017.06.020","article-title":"PDE2 at the crossway between cAMP and cGMP signalling in the heart","volume":"38","author":"Weber","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.114.305892","article-title":"Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2","volume":"117","author":"Zoccarato","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/ars.2016.6687","article-title":"The role of reactive oxygen and nitrogen species in the expression and splicing of nitric oxide receptor","volume":"26","author":"Sharina","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100336","article-title":"Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase","volume":"296","author":"Stuehr","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/cvr\/cvs327","article-title":"Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significance","volume":"97","author":"Sellak","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib84","series-title":"Muscle Cell and Tissue-Novel Molecular Targets and Current Advances","article-title":"Molecular Mechanisms and Targets of Cyclic Guanosine Monophosphate (cGMP) in Vascular Smooth Muscles","author":"Fajmut","year":"2021"},{"key":"10.1016\/j.phrs.2023.106931_bib85","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K","article-title":"Molecular mechanism of cGMP-mediated smooth muscle relaxation","volume":"184","author":"Carvajal","year":"2000","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib86","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.RES.0000059987.90200.44","article-title":"Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle","volume":"92","author":"Seko","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib87","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","article-title":"Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha","volume":"286","author":"Surks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2023.106931_bib88","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.drudis.2012.04.002","article-title":"Function and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cells","volume":"17","author":"Hu","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2023.106931_bib89","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0024-3205(92)90357-U","article-title":"Role of phospholamban in NO\/EDRF-induced relaxation in rat aorta","volume":"51","author":"Karczewski","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib90","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1113\/jphysiol.2001.014126","article-title":"Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes","volume":"540","author":"Layland","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib91","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCHEARTFAILURE.115.002308","article-title":"Molecular screen identifies cardiac myosin-binding protein-C as a protein kinase G-I\u03b1 substrate","volume":"8","author":"Thoonen","year":"2015","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib92","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1016\/S0021-9258(18)77211-6","article-title":"Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP","volume":"265","author":"Thomas","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib93","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1476-5381.2010.00977.x","article-title":"Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5","volume":"161","author":"J\u00e4ger","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib94","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1074\/jbc.M106562200","article-title":"Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells","volume":"277","author":"Rybalkin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1083\/jcb.200107001","article-title":"Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme","volume":"155","author":"Mullershausen","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib96","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","article-title":"Cyclic GMP phosphodiesterases and regulation of smooth muscle function","volume":"93","author":"Rybalkin","year":"2003","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib97","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1126\/science.1144318","article-title":"Cysteine redox sensor in PKGIa enables oxidant-induced activation","volume":"317","author":"Burgoyne","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.phrs.2023.106931_bib98","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2603","article-title":"Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension","volume":"18","author":"Prysyazhna","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib99","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCRESAHA.111.258871","article-title":"H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004740","article-title":"Prevention of PKG-1\u03b1 oxidation suppresses antihypertrophic\/antifibrotic effects from PDE5 inhibition but not sGC stimulation","volume":"11","author":"Nakamura","year":"2018","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib101","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/antiox8090404","article-title":"S-nitrosylation: an emerging paradigm of redox signaling","volume":"8","author":"Fernando","year":"2019","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.phrs.2023.106931_bib102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCRESAHA.109.209452","article-title":"Protein S-nitrosylation and cardioprotection","volume":"106","author":"Sun","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/01.RES.0000202707.79018.0a","article-title":"Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia\/reperfusion injury","volume":"98","author":"Sun","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib104","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/HYPERTENSIONAHA.122.19103","article-title":"S-nitrosylation-mediated reduction of CaV1.2 surface expression and open probability underlies attenuated vasoconstriction induced by nitric oxide","volume":"79","author":"Hu","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cell.2014.09.032","article-title":"Target-selective protein S-nitrosylation by sequence motif recognition","volume":"159","author":"Jia","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2023.106931_bib106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/416337a","article-title":"Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms","volume":"416","author":"Barouch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106931_bib107","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle","volume":"15","author":"Bellinger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib108","doi-asserted-by":"crossref","first-page":"20612","DOI":"10.1073\/pnas.0706796104","article-title":"Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes","volume":"104","author":"Gonzalez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib109","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","article-title":"Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation","volume":"104","author":"Sayed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCRESAHA.108.175133","article-title":"Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance","volume":"103","author":"Sayed","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib111","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1161\/ATVBAHA.115.305796","article-title":"Endothelial nitric oxide synthase-derived nitric oxide prevents dihydrofolate reductase degradation via promoting S-nitrosylation","volume":"35","author":"Cai","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib112","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001974","article-title":"S-nitrosoglutathione reductase deficiency enhances the proliferative expansion of adult heart progenitors and myocytes post myocardial infarction","volume":"4","author":"Hatzistergos","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106931_bib113","first-page":"13","article-title":"S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells","volume":"1","author":"Salerno","year":"2021","journal-title":"J. Cardiovasc. Aging"},{"key":"10.1016\/j.phrs.2023.106931_bib114","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCRESAHA.115.307157","article-title":"S-nitrosylation of calcium-handling proteins in cardiac adrenergic signaling and hypertrophy","volume":"117","author":"Irie","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib115","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1073\/pnas.1113319109","article-title":"Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function","volume":"109","author":"Beigi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2023.106931_bib116","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00282.2016","article-title":"Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications","volume":"312","author":"Szabo","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jare.2020.05.007","article-title":"Hydrogen sulfide and vascular regulation - an update","volume":"27","author":"Lv","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9528-8_1","article-title":"Synthesis, metabolism, and signaling mechanisms of hydrogen sulfide: an overview","volume":"2007","author":"Be\u0142towski","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib119","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphys.2011.00104","article-title":"Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism","volume":"2","author":"Predmore","year":"2011","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101447","article-title":"Hydrogen sulfide stimulates xanthine oxidoreductase conversion to nitrite reductase and formation of NO","volume":"34","author":"Pardue","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib121","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.phrs.2016.06.029","article-title":"Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide","volume":"111","author":"Zhou","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.niox.2014.12.004","article-title":"Role of cGMP in hydrogen sulfide signaling","volume":"46","author":"Bibli","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib123","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.niox.2015.02.095","article-title":"Selectivity of hydrogen sulfide toward cyclic nucleotide phosphodiesterases","volume":"47","author":"Panagiotis","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib124","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/HYPERTENSIONAHA.114.04281","article-title":"Protein kinase G I\u03b1 oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide","volume":"64","author":"Stubbert","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib125","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12515","article-title":"Cardioprotective effects of hydrogen sulfide in attenuating myocardial ischemia reperfusion injury (Review)","volume":"24","author":"Wu","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib126","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF03401781","article-title":"Inducible nitric oxide synthase and inflammatory diseases","volume":"5","author":"Zamora","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib127","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.phrs.2023.106931_bib128","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/pr.57.2.1","article-title":"Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors","volume":"57","author":"Mollace","year":"2005","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2023.106931_bib130","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2174\/0929867323666160729105312","article-title":"Nitric oxide synthase and cyclooxygenase pathways: a complex interplay in cellular signaling","volume":"23","author":"Sorokin","year":"2016","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib131","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1073\/pnas.90.15.7240","article-title":"Nitric oxide activates cyclooxygenase enzymes","volume":"90","author":"Salvemini","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.phrs.2023.106931_bib132","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1172\/JCI118704","article-title":"Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators","volume":"97","author":"Salvemini","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2023.106931_bib133","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.ki.5002058","article-title":"Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes","volume":"71","author":"Cuzzocrea","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2023.106931_bib134","doi-asserted-by":"crossref","first-page":"25934","DOI":"10.1016\/S0021-9258(18)35698-9","article-title":"Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide","volume":"267","author":"Lee","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.STR.29.6.1209","article-title":"Role of inducible nitric oxide synthase and cyclooxygenase-2 in endotoxin-induced cerebral hyperemia","volume":"29","author":"Okamoto","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2023.106931_bib136","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.165.3.1582","article-title":"Nitric oxide synthase\/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production","volume":"165","author":"Clancy","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2023.106931_bib137","first-page":"H1854","article-title":"Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets","volume":"273","author":"Chen","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib138","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/abbi.1994.1400","article-title":"Interaction between nitric oxide and prostaglandin H synthase","volume":"313","author":"Tsai","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2023.106931_bib139","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1016\/S0021-9258(17)32853-3","article-title":"Mechanism for irreversible self-deactivation of prostaglandin synthetase","volume":"251","author":"Egan","year":"1976","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib140","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/ja00117a004","article-title":"Nitric oxide enhances prostaglandin-H synthase-1 activity by a heme-independent mechanism: evidence implicating nitrosothiols","volume":"117","author":"Hajjar","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2023.106931_bib141","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrd2222","article-title":"Peroxynitrite: biochemistry, pathophysiology and development of therapeutics","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"26","key":"10.1016\/j.phrs.2023.106931_bib142","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.93.26.15069","article-title":"Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis","volume":"93","author":"Landino","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib143","doi-asserted-by":"crossref","first-page":"12505","DOI":"10.1021\/bi983049e","article-title":"Regulation of prostaglandin H2 synthase activity by nitrogen oxides","volume":"38","author":"Upmacis","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2023.106931_bib144","doi-asserted-by":"crossref","first-page":"R473","DOI":"10.1152\/ajpregu.00355.2012","article-title":"Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications","volume":"304","author":"Salvemini","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib145","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8364848","article-title":"The dual role of inducible nitric oxide synthase in myocardial ischemia\/reperfusion injury: friend or foe?","volume":"2018","author":"Yu","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phrs.2023.106931_bib146","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.lfs.2005.10.032","article-title":"COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism","volume":"78","author":"Jiang","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib147","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.yjmcc.2010.02.005","article-title":"Beneficial effects of exercise training after myocardial infarction require full eNOS expression","volume":"48","author":"de Waard","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib148","first-page":"153","article-title":"Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states","volume":"15","author":"Tran","year":"2022","journal-title":"Am. J. Biomed. Sci. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib149","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cardiores.2003.09.019","article-title":"Nitric oxide in myocardial ischemia\/reperfusion injury","volume":"61","author":"Schulz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib150","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/CIRCULATIONAHA.108.791533","article-title":"Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia\/reperfusion injury by preventing mitochondrial permeability transition","volume":"118","author":"West","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102370","article-title":"Red blood cell eNOS is cardioprotective in acute myocardial infarction","volume":"54","author":"Cortese-Krott","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib152","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tcm.2012.03.001","article-title":"Role of nNOS in cardiac ischemia-reperfusion injury","volume":"21","author":"Strasen","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib153","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.108.172072","article-title":"Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin","volume":"102","author":"Fisslthaler","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib154","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100938","article-title":"Nitric oxide maintains endothelial redox homeostasis through PKM2 inhibition","volume":"38","author":"Siragusa","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2023.106931_bib155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/cvr\/cvx058","article-title":"Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischaemic insult: role of PYK2","volume":"113","author":"Bibli","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib156","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvt004","article-title":"Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology","volume":"98","author":"Hausenloy","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib157","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2010.02.028","article-title":"In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both","volume":"55","author":"Caballero","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib158","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib159","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/ATVBAHA.108.181628","article-title":"Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia","volume":"30","author":"Taylor","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbabio.2003.06.008","article-title":"Control of cytochrome c oxidase activity by nitric oxide","volume":"1655","author":"Brunori","year":"2004","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2023.106931_bib161","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/01480540903159210","article-title":"Mitigation of mitochondrial dysfunction and regulation of eNOS expression during experimental myocardial necrosis by alpha-mangostin, a xanthonic derivative from Garcinia mangostana","volume":"32","author":"Sampath","year":"2009","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.phrs.2023.106931_bib162","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.freeradbiomed.2016.09.004","article-title":"Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis","volume":"99","author":"Peleli","year":"2016","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib163","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/ATVBAHA.112.300560","article-title":"Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthase","volume":"33","author":"Katakam","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0163-7258(99)00050-9","article-title":"Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers","volume":"85","author":"Fujita","year":"2000","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib165","doi-asserted-by":"crossref","first-page":"H1125","DOI":"10.1152\/ajpheart.00183.2004","article-title":"Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning","volume":"287","author":"Wang","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib166","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1006\/jmcc.2001.1468","article-title":"Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide","volume":"33","author":"Wang","year":"2001","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib167","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/01.CIR.0000145160.04084.AC","article-title":"Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat","volume":"110","author":"Bendall","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib168","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1113\/jphysiol.2008.165423","article-title":"Characteristics and function of cardiac mitochondrial nitric oxide synthase","volume":"587","author":"Dedkova","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib169","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.RES.0000078171.52542.9E","article-title":"Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases","volume":"92","author":"Khan","year":"2003","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib170","doi-asserted-by":"crossref","first-page":"C144","DOI":"10.1152\/ajpcell.00150.2016","article-title":"Threshold levels of extracellular l-arginine that trigger NOS-mediated ROS\/RNS production in cardiac ventricular myocytes","volume":"312","author":"Ramachandran","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib171","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/antiox11061069","article-title":"Yin and Yang of NADPH oxidases in myocardial ischemia-reperfusion","volume":"11","author":"Matsushima","year":"2022","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.phrs.2023.106931_bib172","series-title":"The Newborn Lung","first-page":"91","article-title":"Hypoxia and Hyperoxia: Effects on the Newborn Pulmonary Circulation","author":"Wedgwood","year":"2012"},{"key":"10.1016\/j.phrs.2023.106931_bib173","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11897-012-0097-5","article-title":"Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling","volume":"9","author":"Alkaitis","year":"2012","journal-title":"Curr. Heart Fail Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-06758-8","article-title":"Role of endothelial colony forming cells (ECFCs) Tetrahydrobiopterin (BH4) in determining ECFCs functionality in coronary artery disease (CAD) patients","volume":"12","author":"Sen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib175","article-title":"The critical role of tetrahydrobiopterin (BH4) metabolism in modulating radiosensitivity: BH4\/NOS axis as an angel or a devil","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2023.106931_bib176","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/cvr\/cvr087","article-title":"Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology","volume":"91","author":"Nishijima","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104827","article-title":"Tetrahydrobiopterin in energy metabolism and metabolic diseases","volume":"157","author":"Kim","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76948-9","article-title":"Tetrahydrobiopterin prevents chronic ischemia-related lower urinary tract dysfunction through the maintenance of nitric oxide bioavailability","volume":"10","author":"Akaihata","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib179","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1161\/01.CIR.102.18.2172","article-title":"Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis","volume":"102","author":"Tiefenbacher","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.CIR.0000137831.08683.E1","article-title":"Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice","volume":"110","author":"Liao","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib181","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00414-019-02051-y","article-title":"Increased inducible nitric oxide synthase (iNOS) expression in human myocardial infarction","volume":"134","author":"Wilmes","year":"2020","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10050749","article-title":"Implications of oxidative and nitrosative post-translational modifications in therapeutic strategies against reperfusion damage","author":"Buelna-Chontal","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.phrs.2023.106931_bib183","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1161\/CIRCULATIONAHA.108.791533","article-title":"Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia\/reperfusion injury by preventing mitochondrial permeability transition","volume":"118","author":"West","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2023.106931_bib184","first-page":"544","article-title":"Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning","volume":"59","author":"Sun","year":"2007","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.phrs.2023.106931_bib185","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCRESAHA.107.155879","article-title":"Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport","volume":"101","author":"Sun","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib186","series-title":"Free Radicals, Antioxidants and Diseases","article-title":"Cardioprotective Effects of S-Nitrosothiols in Ischemia- Reperfusion: Role for Mitochondria and Calcium Channels","author":"Arriagada","year":"2018"},{"key":"10.1016\/j.phrs.2023.106931_bib187","article-title":"Targeting calcium homeostasis in myocardial ischemia\/reperfusion injury: an overview of regulatory mechanisms and therapeutic reagents","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib188","doi-asserted-by":"crossref","first-page":"37448","DOI":"10.1074\/jbc.M707543200","article-title":"S-nitrosation of mitochondrial complex I depends on its structural conformation","volume":"282","author":"Galkin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib189","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbagen.2011.03.008","article-title":"Regulation of mitochondrial processes by protein S-nitrosylation","volume":"1820","author":"Piantadosi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2023.106931_bib190","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1073\/pnas.95.13.7631","article-title":"Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione","volume":"95","author":"Clementi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib191","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.freeradbiomed.2018.06.040","article-title":"Attenuation of oxidative damage by targeting mitochondrial complex I in neonatal hypoxic-ischemic brain injury","volume":"124","author":"Kim","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib192","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2018.02.006","article-title":"Mitochondrial protein S-nitrosation protects against ischemia reperfusion-induced denervation at neuromuscular junction in skeletal muscle","volume":"117","author":"Wilson","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib193","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.3212","article-title":"Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I","volume":"19","author":"Chouchani","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib194","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2022.05.013","article-title":"Regulation of endothelial nitric oxide synthase in cardiac remodeling","volume":"364","author":"Musicante","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphys.2012.00105","article-title":"Nitric oxide synthases and atrial fibrillation","volume":"3","author":"Bonilla","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib196","doi-asserted-by":"crossref","first-page":"340ra74","DOI":"10.1126\/scitranslmed.aac4296","article-title":"Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase","volume":"8","author":"Reilly","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib197","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.108.846402","article-title":"Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice","volume":"120","author":"Burger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib198","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1161\/CIRCULATIONAHA.105.539437","article-title":"nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction","volume":"112","author":"Dawson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib199","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib200","first-page":"3219","article-title":"beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current","volume":"118","author":"Skeberdis","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106931_bib201","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.jacc.2011.12.046","article-title":"Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase","volume":"59","author":"Niu","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI9323","article-title":"beta (3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility","volume":"106","author":"Varghese","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106931_bib203","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/jcm9061995","article-title":"Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets","volume":"9","author":"Scioli","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib204","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ijms20010187","article-title":"New therapeutic implications of endothelial nitric oxide synthase (eNOS) function\/dysfunction in cardiovascular disease","volume":"20","author":"Daiber","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102406","article-title":"Increased NOS coupling by the metabolite tetrahydrobiopterin (BH4) reduces preeclampsia\/IUGR consequences","volume":"55","author":"Chatre","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib206","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.3390\/ijms23115979","article-title":"Disruption of redox homeostasis by alterations in nitric oxide synthase activity and tetrahydrobiopterin along with melanoma progression","volume":"23","author":"Soares","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib207","doi-asserted-by":"crossref","first-page":"28128","DOI":"10.1074\/jbc.M109.041483","article-title":"Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib208","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1074\/jbc.M805403200","article-title":"Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression","volume":"284","author":"Crabtree","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib209","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1073\/pnas.1505556112","article-title":"Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart","volume":"112","author":"Reyes","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.freeradbiomed.2017.01.012","article-title":"A novel role for endothelial tetrahydrobiopterin in mitochondrial redox balance","volume":"104","author":"Bailey","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib211","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/biomedicines10102479","article-title":"Tetrahydrobiopterin (BH4) supplementation prevents the cardiorenal effects of diabetes in mice by reducing oxidative stress, inflammation and fibrosis","volume":"10","author":"Novoa","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2023.106931_bib212","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib213","doi-asserted-by":"crossref","first-page":"568S","DOI":"10.1093\/jn\/131.2.568S","article-title":"Iron biology in immune function, muscle metabolism and neuronal functioning","volume":"131","author":"Beard","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2023.106931_bib214","doi-asserted-by":"crossref","first-page":"48410-6","DOI":"10.1074\/jbc.M108362200","article-title":"Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging","volume":"276","author":"Atamna","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jcla.20335","article-title":"Oxidative status in iron-deficiency anemia","volume":"23","author":"Yoo","year":"2009","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.phrs.2023.106931_bib216","first-page":"S18","article-title":"Oxidative stress in anemia","volume":"53","author":"Grune","year":"2000","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.phrs.2023.106931_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-001-0409-4","article-title":"Iron deficiency anemia increases nitric oxide production in healthy adolescents","volume":"81","author":"Choi","year":"2002","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.phrs.2023.106931_bib218","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ki.1997.319","article-title":"Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia","volume":"52","author":"Ni","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2023.106931_bib219","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/CS20040278","article-title":"Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration","volume":"109","author":"Dong","year":"2005","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2023.106931_bib220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/BTER:96:1-3:117","article-title":"Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia","volume":"96","author":"Kurtoglu","year":"2003","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib221","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.113.005924","article-title":"R is for arginine: metabolism of arginine takes off again, in new directions","volume":"128","author":"Michel","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib222","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.niox.2016.02.006","article-title":"Effect of asymmetric dimethylarginine (ADMA) on heart failure development","volume":"54","author":"Liu","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib223","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib224","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/toxins9030092","article-title":"Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA)","volume":"9","author":"Tain","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.phrs.2023.106931_bib225","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04075-0","article-title":"A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach","volume":"26","author":"Singh","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.phrs.2023.106931_bib226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1568026611313020007","article-title":"Asymmetric dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?","volume":"13","author":"Bouras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib227","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nature09599","article-title":"S-glutathionylation uncouples eNOS and regulates its cellular and vascular function","volume":"468","author":"Chen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106931_bib228","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/molecules26020435","article-title":"Glutathione in protein redox modulation through S-Glutathionylation and S-Nitrosylation","volume":"26","author":"Kalinina","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2023.106931_bib229","doi-asserted-by":"crossref","first-page":"378","DOI":"10.14336\/AD.2019.09603","article-title":"Caveolin as a novel potential therapeutic target in cardiac and vascular diseases: a mini review","volume":"11","author":"Tian","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.phrs.2023.106931_bib230","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1152\/physrev.2001.81.4.1415","article-title":"Ion channels and their functional role in vascular endothelium","volume":"81","author":"Nilius","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2023.106931_bib231","article-title":"Perivascular adipose tissue inhibits endothelial function of rat aortas via caveolin-1","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106931_bib232","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.112.196667","article-title":"Apolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase","volume":"60","author":"Yue","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib233","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.2337\/dbi15-0005","article-title":"Caveolin-1 in cardiovascular disease: a double-edged sword","volume":"64","author":"Jia","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2023.106931_bib234","doi-asserted-by":"crossref","first-page":"96","DOI":"10.33963\/KP.15203","article-title":"The essential role of a \"healthy\" relationship between caveolin-1 and endothelial nitric oxide synthase in counteracting vascular inflammation and atherothrombosis","volume":"78","author":"Mollace","year":"2020","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.phrs.2023.106931_bib235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2015.10.157","article-title":"The potential role of TLR4\/caveolin-1\/NOS pathway in oxyLDL-modulation of autophagic\/apoptotic responses in endothelial cells","volume":"203","author":"Mollace","year":"2016","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib236","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1073\/pnas.1003833107","article-title":"Shear stress, SIRT1, and vascular homeostasis","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib237","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/ars.2016.6719","article-title":"CR6-interacting factor 1 deficiency impairs vascular function by inhibiting the Sirt1-endothelial nitric oxide synthase pathway","volume":"27","author":"Nagar","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib238","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2015.6591","article-title":"Thiol-based redox modulation of soluble guanylyl cyclase, the nitric oxide receptor","volume":"26","author":"Beuve","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib239","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2023.106931_bib240","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/ijms19061712","article-title":"The impact of the nitric oxide (NO)\/soluble guanylyl cyclase (sGC) signaling cascade on kidney health and disease: a preclinical perspective","volume":"19","author":"Krishnan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib241","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCRESAHA.117.310705","article-title":"Cytochrome b5 reductase 3 modulates soluble guanylate cyclase redox state and cGMP signaling","volume":"121","author":"Rahaman","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib242","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129183","article-title":"Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation","volume":"4","author":"Durgin","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2023.106931_bib243","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2021.09.005","article-title":"Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress","volume":"162","author":"Durgin","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib244","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9482","article-title":"Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice","volume":"6","author":"Thoonen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2023.106931_bib245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-540-68964-5_12","article-title":"NO and sGC-stimulating NO donors","volume":"191","author":"Megson","year":"2009","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib246","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib247","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.aju.2013.07.009","article-title":"Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: current information and new horizons","volume":"11","author":"Ferguson 3rd","year":"2013","journal-title":"Arab J. Urol."},{"key":"10.1016\/j.phrs.2023.106931_bib248","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2018.12.002","article-title":"Differential expressions and functions of phosphodiesterase enzymes in different regions of the rat heart","volume":"844","author":"Derici","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib249","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11906-013-0377-9","article-title":"Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension","volume":"15","author":"Chrysant","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib250","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib251","doi-asserted-by":"crossref","first-page":"H1263","DOI":"10.1152\/ajpheart.00324.2002","article-title":"Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits","volume":"283","author":"Ockaili","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib252","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01052.2001","article-title":"ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes","volume":"283","author":"Han","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib253","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.ajpheart.91438.2007","article-title":"Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice","volume":"294","author":"Salloum","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib254","doi-asserted-by":"crossref","first-page":"H2272","DOI":"10.1152\/ajpheart.00654.2010","article-title":"Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA\/Rho-kinase pathway","volume":"300","author":"Chau","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib255","doi-asserted-by":"crossref","first-page":"H1236","DOI":"10.1152\/ajpheart.00100.2009","article-title":"ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice","volume":"296","author":"Das","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib256","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.109.906818","article-title":"Oxidative stress regulates left ventricular PDE5 expression in the failing heart","volume":"121","author":"Lu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib257","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.3390\/nu13114070","article-title":"Icariin protects H9c2 rat cardiomyoblasts from doxorubicin-induced cardiotoxicity: role of caveolin-1 upregulation and enhanced autophagic response","volume":"13","author":"Scicchitano","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106931_bib258","doi-asserted-by":"crossref","first-page":"H387","DOI":"10.1152\/ajpheart.00169.2009","article-title":"Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury","volume":"297","author":"Ahmad","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib259","doi-asserted-by":"crossref","first-page":"S31-6","DOI":"10.1161\/CIRCULATIONAHA.108.843979","article-title":"Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia\/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide","volume":"120","author":"Salloum","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib260","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.111.081125","article-title":"Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis","volume":"125","author":"Lindman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib261","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccl.2011.06.004","article-title":"Ventricular-vascular interaction in heart failure","volume":"29","author":"Borlaug","year":"2011","journal-title":"Cardiol. Clin."},{"key":"10.1016\/j.phrs.2023.106931_bib262","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2010.08.612","article-title":"Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5","volume":"56","author":"Zhang","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib263","doi-asserted-by":"crossref","first-page":"1200-8","DOI":"10.1161\/CIRCULATIONAHA.112.000056","article-title":"Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial","volume":"127","author":"Andersen","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib264","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib265","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib266","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/eurjhf\/hfr147","article-title":"Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study","volume":"14","author":"Guazzi","year":"2012","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib267","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2007.03.118","article-title":"Sildenafil improves the alveolar-capillary function in heart failure patients","volume":"126","author":"Bussotti","year":"2008","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib268","doi-asserted-by":"crossref","first-page":"115","DOI":"10.14797\/RKQN5397","article-title":"Management of Pulmonary Hypertension in Left Heart Disease","volume":"17","author":"Macera","year":"2021","journal-title":"Methodist Debakey Cardiovasc J."},{"key":"10.1016\/j.phrs.2023.106931_bib269","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCHEARTFAILURE.114.001915","article-title":"Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction","volume":"8","author":"Borlaug","year":"2015","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib270","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2017.05.079","article-title":"Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design","volume":"243","author":"Tobler","year":"2017","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib271","first-page":"OA1501","article-title":"Goal orientated strategy to preserve right ventricular ejection fraction trial (GOSPEL trial)","volume":"50","author":"In 't Veld","year":"2017"},{"key":"10.1016\/j.phrs.2023.106931_bib272","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(20)30532-4","article-title":"Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicenter, open-label, randomised controlled trial","volume":"9","author":"Hoeper","year":"2021","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib273","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/164_2016_100","article-title":"Novel sGC stimulators and sGC activators for the treatment of heart failure","volume":"243","author":"Breitenstein","year":"2017","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib274","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.106.083832","article-title":"Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure","volume":"49","author":"Boerrigter","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/164_2019_249","article-title":"Correction to: soluble guanylate cyclase stimulators and activators","volume":"264","author":"Sandner","year":"2021","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib276","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","article-title":"Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling","volume":"113","author":"Dumitrascu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib277","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-015-0309-x","article-title":"The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus","volume":"14","author":"M\u00e1ty\u00e1s","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.phrs.2023.106931_bib278","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1165\/rcmb.2017-0292OC","article-title":"Nitric oxide-independent soluble guanylate cyclase activation improves vascular function and cardiac remodeling in sickle cell disease","volume":"58","author":"Potoka","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib279","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083910","article-title":"Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI\/PET imaging","volume":"8","author":"Methner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106931_bib280","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00090614","article-title":"Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)","volume":"45","author":"Rubin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2023.106931_bib281","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.00105914","article-title":"PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension","volume":"45","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.phrs.2023.106931_bib282","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.healun.2021.06.020","article-title":"Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"40","author":"Benza","year":"2021","journal-title":"J. Heart Lung Transpl."},{"key":"10.1016\/j.phrs.2023.106931_bib283","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0957-y","article-title":"Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)","volume":"19","author":"Marra","year":"2018","journal-title":"Respir. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib284","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.14-0106","article-title":"Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study","volume":"146","author":"Bonderman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2023.106931_bib285","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2023.106931_bib286","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib287","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib288","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.3390\/ijms22179546","article-title":"The role of the BH4 cofactor in nitric oxide synthase activity and cancer progression: two sides of the same coin","volume":"22","author":"Gon\u00e7alves","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib289","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1161\/CIRCULATIONAHA.107.737031","article-title":"Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy","volume":"117","author":"Moens","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib290","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.0000162470.26840.89","article-title":"Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension","volume":"111","author":"Khoo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib291","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1073\/pnas.0702986104","article-title":"Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4","volume":"104","author":"Dumitrescu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib292","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/mtc.2002.124393","article-title":"Beneficial effect of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts","volume":"124","author":"Yamashiro","year":"2002","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"10.1016\/j.phrs.2023.106931_bib293","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2023.106931_bib294","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.jhh.1002329","article-title":"Tetrahydrobiopterin: a novel antihypertensive therapy","volume":"22","author":"Porkert","year":"2008","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.phrs.2023.106931_bib295","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2022.36.S1.R3751","article-title":"The impact of short-term tetrahydrobiopterin (BH4) supplementation on peripheral vascular function in heart failure with preserved ejection fraction (HFpEF)","volume":"36","author":"Bunsawat","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2023.106931_bib296","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib297","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.niox.2011.04.004","article-title":"Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease","volume":"25","author":"Crabtree","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib298","doi-asserted-by":"crossref","first-page":"H2167","DOI":"10.1152\/ajpheart.00935.2001","article-title":"Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function","volume":"282","author":"Hyndman","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib299","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00952.2003","article-title":"Treatment of coronary heart disease with folic acid: is there a future?","volume":"287","author":"Moat","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib300","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3892\/mmr.2014.2332","article-title":"High dose folic acid improves endothelial function by increasing tetrahydrobiopterin and decreasing homocysteine levels","volume":"10","author":"Zhang","year":"2014","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.phrs.2023.106931_bib301","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1089\/ars.2015.6329","article-title":"Folic acid promotes recycling of tetrahydrobiopterin and protects against hypoxia-induced pulmonary hypertension by recoupling endothelial nitric oxide synthase","volume":"23","author":"Chalupsky","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib302","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/hc0102.101388","article-title":"Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering","volume":"105","author":"Doshi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib303","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.106.679084","article-title":"Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease","volume":"115","author":"Shirodaria","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib304","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2023.106931_bib305","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003768","article-title":"Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"5","author":"Li","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106931_bib306","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ijc.30094","article-title":"Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial","volume":"141","author":"Qin","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2023.106931_bib307","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000653","article-title":"Cancer risk with folic acid supplements: a systematic review and meta-analysis","volume":"2","author":"Wien","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.phrs.2023.106931_bib308","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1055-9965.EPI-17-1198","article-title":"Folic acid and vitamin B12 supplementation and the risk of cancer: long-term follow-up of the B vitamins for the prevention of osteoporotic fractures (B-PROOF) trial","volume":"28","author":"Oliai Araghi","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.phrs.2023.106931_bib309","first-page":"64","article-title":"Iron deficiency in chronic heart failure: case-based practical guidance","volume":"5","author":"Lam","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron Deficiency in Heart Failure","volume":"7","author":"von Haehling","year":"2019","journal-title":"Overv., JACC Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib311","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib312","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib313","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.3390\/nu14235057","article-title":"Effect of ferric carboxymaltose supplementation in patients with heart failure with preserved ejection fraction: role of attenuated oxidative stress and improved endothelial function","volume":"14","author":"Mollace","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106931_bib314","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pharmthera.2006.11.002","article-title":"The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO","volume":"113","author":"Paolocci","year":"2007","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib315","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1073\/pnas.162095599","article-title":"The reduction potential of nitric oxide (NO) and its importance to NO biochemistry","volume":"99","author":"Bartberger","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib316","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6904327","article-title":"Interaction of hydrogen sulfide with nitric oxide in the cardiovascular system","volume":"2016","author":"Nagpure","year":"2016","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.phrs.2023.106931_bib317","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1089\/ars.2010.3859","article-title":"Playing with cardiac \"redox switches\": the \"HNO way\" to modulate cardiac function","volume":"14","author":"Tocchetti","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2023.106931_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104961","article-title":"Role of nitroxyl (HNO) in cardiovascular system: from biochemistry to pharmacology","volume":"159","author":"Sun","year":"2020","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib319","first-page":"614","article-title":"Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+-cycling","volume":"2","author":"Kohr","year":"2010","journal-title":"Front Biosci. (Elite Ed. )"},{"key":"10.1016\/j.phrs.2023.106931_bib320","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","article-title":"The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature","volume":"73","author":"Favaloro","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2023.106931_bib321","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib322","article-title":"Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106931_bib323","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.12.017","article-title":"The opposing roles of NO and oxidative stress in cardiovascular disease","volume":"116","author":"Ritchie","year":"2017","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib324","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCHEARTFAILURE.113.000632","article-title":"Nitroxyl (HNO): a novel approach for the acute treatment of heart failure","volume":"6","author":"Sabbah","year":"2013","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib325","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/ejhf.897","article-title":"A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction","volume":"19","author":"Tita","year":"2017","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib326","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jchf.2020.10.012","article-title":"Effects of a novel nitroxyl donor in acute heart failure: the STAND-UP AHF study","volume":"9","author":"Felker","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib327","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ejhf.1504","article-title":"Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure","volume":"21","author":"Felker","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib328","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1152\/japplphysiol.00371.2019","article-title":"Influence of dietary inorganic nitrate on blood pressure and vascular function in hypertension: prospective implications for adjunctive treatment","volume":"127","author":"Broxterman","year":"2019","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib329","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.niox.2021.04.006","article-title":"Effect of inorganic nitrate supplementation on blood pressure in older adults: a systematic review and meta-analysis","volume":"114","author":"He","year":"2021","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib330","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.120.14930","article-title":"Effects of oral sodium nitrite on blood pressure, insulin sensitivity, and intima-media arterial thickening in adults with hypertension and metabolic syndrome","volume":"76","author":"Hughan","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib331","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nchembio.260","article-title":"Nitrate and nitrite in biology, nutrition and therapeutics","volume":"5","author":"Lundberg","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib332","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehu096","article-title":"Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)","volume":"35","author":"Siddiqi","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib333","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.116.305082","article-title":"Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction","volume":"116","author":"Jones","year":"2015","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib334","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/heartjnl-2016-309748","article-title":"Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention","volume":"103","author":"Jones","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.phrs.2023.106931_bib335","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","author":"Haykowsky","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib336","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/gerona\/glt011","article-title":"Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass","volume":"68","author":"Haykowsky","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"10.1016\/j.phrs.2023.106931_bib337","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCRESAHA.116.309184","article-title":"Inhaled sodium nitrite improves rest and exercise hemodynamics in heart failure with preserved ejection fraction","volume":"119","author":"Borlaug","year":"2016","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib338","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.114.012957","article-title":"Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction","volume":"131","author":"Zamani","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib339","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib340","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2023.106931_bib341","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6579\/aab2ef","article-title":"Effect of organic and inorganic nitrates on cerebrovascular pulsatile power transmission in patients with heart failure and preserved ejection fraction","volume":"39","author":"Londono-Hoyos","year":"2018","journal-title":"Physiol. Meas."},{"key":"10.1016\/j.phrs.2023.106931_bib342","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.niox.2017.05.005","article-title":"Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and\/or heart failure with preserved ejection fraction","volume":"69","author":"Shaltout","year":"2017","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2023.106931_bib343","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1054666","article-title":"Efficacy and safety of inorganic nitrate\/nitrite supplementary therapy in heart failure with preserved ejection fraction","volume":"10","author":"Lv","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.phrs.2023.106931_bib344","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.116.08081","article-title":"Blood pressure-lowering effect of orally ingested nitrite is abolished by a proton pump inhibitor","volume":"69","author":"Montenegro","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib345","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.117.09016","article-title":"Conjugated linoleic acid modulates clinical responses to oral nitrite and nitrate","volume":"70","author":"Hughan","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2023.106931_bib346","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1074\/jbc.275.9.6123","article-title":"Enhanced electron flux and reduced calmodulin dissociation may explain \"calcium-independent\" eNOS activation by phosphorylation","volume":"275","author":"McCabe","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib347","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jcmm.12077","article-title":"Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells","volume":"17","author":"Altaany","year":"2013","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib348","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.004093","article-title":"Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor-dependent angiogenesis","volume":"1","author":"Bir","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106931_bib349","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/ATVBAHA.110.209783","article-title":"Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity","volume":"30","author":"Bucci","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2023.106931_bib350","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2023.106931_bib351","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.1202916109","article-title":"Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation","volume":"109","author":"Coletta","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2023.106931_bib352","doi-asserted-by":"crossref","first-page":"H2410-8","DOI":"10.1152\/ajpheart.00044.2012","article-title":"The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability","volume":"302","author":"Predmore","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib353","doi-asserted-by":"crossref","first-page":"15560-5","DOI":"10.1073\/pnas.0705891104","article-title":"Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function","volume":"104","author":"Elrod","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2023.106931_bib354","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1755-5922.12128","article-title":"A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients","volume":"33","author":"Polhemus","year":"2015","journal-title":"Cardiovasc Ther."},{"key":"10.1016\/j.phrs.2023.106931_bib355","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ahj.2021.08.012","article-title":"Rationale and design of the groningen intervention study for the preservation of cardiac function with sodium thiosulfate after st-segment elevation myocardial infarction (GIPS-IV) trial","volume":"243","author":"de Koning","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib356","unstructured":"\u3008https:\/\/www.escardio.org\/Congresses-Events\/ESC-TV\/ESC-Expert-Insights-at-ACC22#gips-iv\u3009."},{"key":"10.1016\/j.phrs.2023.106931_bib357","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.yjmcc.2010.02.011","article-title":"Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system","volume":"48","author":"Moens","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib358","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/01.CIR.103.12.1649","article-title":"Upregulation of beta (3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2023.106931_bib359","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/eurheartj\/ehx366","article-title":"Cardiac myocyte \u03b23-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling","volume":"39","author":"Hermida","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106931_bib360","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI2191","article-title":"The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle","volume":"102","author":"Gauthier","year":"1998","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106931_bib361","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ejhf.62","article-title":"Tocchetti paper from the Working Group on Myocardial Function of the European Society of Cardiology","volume":"16","author":"Tarone","year":"2014","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib362","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ejhf.714","article-title":"The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial","volume":"19","author":"Bundgaard","year":"2017","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib363","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.113.004940","article-title":"Enhanced expression of \u03b23-adrenoceptors in cardiac myocytes attenuC.ates neurohormone-induced hypertrophic remodeling through nitric oxide synthase","volume":"129","author":"Belge","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2023.106931_bib364","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ehf2.12306","volume":"5","author":"Pouleur","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib365","unstructured":"\u3008https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/mirabegron-is-safe-but-fails-to-prevent-remodelling-in-patients-with-mild-heart\u3009."},{"key":"10.1016\/j.phrs.2023.106931_bib366","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009120","article-title":"Hemodynamic effects of cyclic guanosine monophosphate-dependent signaling through \u03b23 adrenoceptor stimulation in patients with advanced heart failure: a randomized invasive clinical trial","volume":"15","author":"Bundgaard","year":"2022","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib367","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006753","article-title":"Targeting cardiac myocyte Na+-K+ pump function with \u03b23 adrenergic agonist in rabbit model of severe congestive heart failure","volume":"13","author":"Fry","year":"2020","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib368","article-title":"The role of oxidative stress in cardiac disease: from physiological response to injury factor","volume":"14","author":"D'Oria","year":"2020","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.phrs.2023.106931_bib369","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1570161054368607","article-title":"Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure","volume":"3","author":"Ungv\u00e1ri","year":"2005","journal-title":"Curr. Vasc. Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib370","article-title":"Natural drugs as a treatment strategy for cardiovascular disease through the regulation of oxidative stress","volume":"27","author":"Chang","year":"2020","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.phrs.2023.106931_bib371","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/CIR.0000000000001110","article-title":"Complementary and alternative medicines in the management of heart failure: a scientific statement from the American Heart Association","volume":"147","author":"Chow","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2023.106931_bib372","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jpp\/rgac092","article-title":"Dietary supplements and medicinal plants in urolithiasis: diet, prevention, and cure","volume":"75","author":"Oswal","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106931_bib373","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4295802","article-title":"Plant bioactives in the treatment of inflammation of skeletal muscles: a molecular perspective","volume":"2022","author":"Karati","year":"2022","journal-title":"Evid. Based Complement Altern. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib374","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000363364","article-title":"Coenzyme Q and the respiratory chain: coenzyme Q pool and mitochondrial supercomplexes","volume":"5","author":"Enriqueza","year":"2014","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.phrs.2023.106931_bib375","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrfmmm.2011.09.004","article-title":"Micronutrient special issue: coenzyme Q(10) requirements for DNA damage prevention","volume":"733","author":"Schmelzer","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.phrs.2023.106931_bib376","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cell.2013.01.013","article-title":"Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis","volume":"152","author":"Mugoni","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2023.106931_bib377","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002639","article-title":"Coenzyme Q10 and heart failure: a state-of-the-art review","volume":"9","author":"Sharma","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib378","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: A randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.phrs.2023.106931_bib379","first-page":"CD008684","article-title":"Coenzyme Q10 for heart failure","volume":"2","author":"Al Saadi","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2023.106931_bib380","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/nu13010257","article-title":"Pathophysiological basis for nutraceutical supplementation in heart failure: a comprehensive review","volume":"13","author":"Mollace","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106931_bib381","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-5273(95)02320-V","article-title":"Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure","volume":"49","author":"Bharani","year":"1995","journal-title":"Int J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib382","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02836502","article-title":"Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure]","volume":"11","author":"Zhang","year":"2005","journal-title":"Chin. J. Integr. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib383","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mnfr.200500118","article-title":"The role of tea and tea flavonoids in cardiovascular health","volume":"50","author":"Stangl","year":"2006","journal-title":"Mol. Nutr. Food Res"},{"key":"10.1016\/j.phrs.2023.106931_bib384","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1515\/BC.2008.095","article-title":"Epigallocatechin gallate inhibits endothelial exocytosis","volume":"389","author":"Yamakuchi","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib385","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.RES.0000168807.63013.56","article-title":"p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols","volume":"96","author":"Anter","year":"2005","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106931_bib386","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cardiores.2006.08.022","article-title":"Molecular targets of tea polyphenols in the cardiovascular system","volume":"73","author":"Stangl","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"Spring;5(1)","key":"10.1016\/j.phrs.2023.106931_bib387","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/109662002753723160","article-title":"Inhibitory activity of minor polyphenolic and nonpolyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation","volume":"5","author":"Andrikopoulos","year":"2002","journal-title":"J. Med Food"},{"key":"10.1016\/j.phrs.2023.106931_bib388","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/jn\/136.8.2213","article-title":"The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits","volume":"136","author":"Andreadou","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.phrs.2023.106931_bib389","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ejhf.61","article-title":"Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial","volume":"16","author":"Fit\u00f3","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100084","article-title":"The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial","volume":"9","author":"Casas","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.phrs.2023.106931_bib391","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1021\/jf0112973","article-title":"Plant foods and herbal sources of resveratrol","volume":"50","author":"Burns","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2023.106931_bib392","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.freeradbiomed.2007.05.004","article-title":"Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase","volume":"43","author":"Thirunavukkarasu","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib393","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/nu11010105","article-title":"Protective effect of resveratrol against ischemia-reperfusion injury via enhanced high energy compounds and eNOS-SIRT1 expression in type 2 diabetic female rat heart","volume":"11","author":"Fourny","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106931_bib394","first-page":"286","article-title":"Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease Wiad","volume":"70","author":"Chekalina","year":"2017","journal-title":"Lek"},{"key":"10.1016\/j.phrs.2023.106931_bib395","article-title":"A new therapeutic candidate for cardiovascular diseases: berberine","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol. Front Pharmacol."},{"key":"10.1016\/j.phrs.2023.106931_bib396","article-title":"Multi-pharmacology of berberine in atherosclerosis and metabolic diseases: potential contribution of gut microbiota","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2023.106931_bib397","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2022.11298","article-title":"Berberine attenuates sepsis-induced cardiac dysfunction by upregulating the Akt\/eNOS pathway in mice","volume":"23","author":"Zhang","year":"2022","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.phrs.2023.106931_bib398","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.565751","article-title":"Berberine promotes cardiac function by upregulating PINK1\/Parkin-mediated mitophagy in heart failure","volume":"11","author":"Abudureyimu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2023.106931_bib399","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9149(03)00533-2","article-title":"Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"92","author":"Zeng","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib400","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2021.05.013","article-title":"Redox signaling in heart failure and therapeutic implications","volume":"171","author":"Weissman","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2023.106931_bib401","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"Van Der Pol","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2023.106931_bib402","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2018.04.007","article-title":"Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced cardiomyopathy: role of autophagy and ckitposCD45negCD31neg cardiac stem cell activation","volume":"119","author":"Carresi","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2023.106931_bib403","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-019-1061-0","article-title":"The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia","volume":"18","author":"Musolino","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2023.106931_bib404","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1871530319666181203151513","article-title":"Hypoglycemic and hypolipemic effects of a new lecithin formulation of bergamot polyphenolic fraction: a double blind, randomized, placebo-controlled study","volume":"19","author":"Mollace","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2023.106931_bib405","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/bph.13704","article-title":"Effect of hypercholesterolaemia on myocardial function, ischaemia\u2013reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning","volume":"174","author":"Andreadou","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2023.106931_bib406","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/nu14030477","article-title":"Comparative effect of bergamot polyphenolic fraction and red yeast rice extract in rats fed a hyperlipidemic diet: role of antioxidant properties and PCSK9 expression","volume":"14","author":"Mollace","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2023.106931_bib407","first-page":"053","article-title":"Bergamot polyphenolic fraction supplementation improves metabolic balance, endothelial function and maximal oxygen uptake in athletes","volume":"3","author":"Mollace","year":"2018","journal-title":"J. Sports Med Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:48:28Z","timestamp":1760914108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":407,"alternative-id":["S1043661823002876"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106931","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}